Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Today's biggest pre-market stock movers: 10 top gainers and losers on Tuesday
Welcome back, investors, and I hope you all enjoyed the July 4th weekend! We're getting right back into the swing of things today with a look at the biggest pre-market stock movers for Tuesday!
歡迎回來，投資者們，我希望你們都喜歡7月4日的週末！今天我們馬上回到正題，來看看週二最大的盤前股票走勢吧！。
Let's jump right into those pre-market stock movers below!
讓我們直接跳到下面那些開盤前的股票行情中去吧！
Pre-Market Stock Movers: 10 Top Gainers
盤前股票交易商：10大漲幅最大的股票
$Advaxis Inc(ADXS.US)$ stock is rocketing more than 65% this morning after announcing a merger deal with Biosight.
$Bridgeline Digital Inc(BLIN.US)$ shares are soaring over 38% after revealing it gained more than $2.5 million in cash last week from warrant exercises.
$BSQUARE Corp(BSQR.US)$ stock is rising more than 34% in pre-market trading today.
$IVERIC bio Inc(ISEE.US)$ shares are heading over 33% higher after announcing a written agreement from the FDA for a Special Protocol Assessment for its Phase 3 clinical trial of Zimura to treat geographic atrophy secondary to age-related macular degeneration.
$Odonate Therapeutics Inc(ODT.US)$ stock is climbing nearly 33% after revealing an increased stake from Ikarian Capital in an SEC filing.
$Axcella Health Inc(AXLA.US)$ shares were up close to 28% as of this morning.
$Marin Software Inc(MRIN.US)$ stock is gaining more than 20% as Reddit continues to favor the company.
$Ocugen Inc(OCGN.US)$ shares are increasing over 16% after revealing trial results from its coronavirus vaccine being developed with Bharat Biotech.
$Sequential Brands Group Inc(SQBG.US)$ stock is running more than 16% higher after seeing heavy trading on Friday.
$Immutep Ltd(IMMP.US)$ shares are jumping over 11% after revealing IRB approval for a Phase IIb clinical trial that will start this quarter.
$Advaxis Inc.(ADXS.US)$今天上午，在宣佈與Biosight達成合並協議後，該公司股價飆升了65%以上。
$Bridgeline Digital Inc.(BLIN.US)$在透露上週通過權證交易獲得了超過250萬美元的現金後，該公司股價飆升了38%以上。
$BSQUARE Corp(BSQR.US)$今日盤前交易中，該股漲幅超過34%。
$IVERIC BIO Inc.(ISEE.US)$在宣佈FDA為其Zimura第三階段臨牀試驗治療繼發於年齡相關性黃斑變性的地理萎縮進行特殊協議評估後，股價上漲了33%以上。
$Odonate治療公司(ODT.US)$在美國證券交易委員會(SEC)提交給美國證券交易委員會(SEC)的文件中披露Ikarian Capital增持股份後，該公司股價上漲近33%。
$Axcella Health Inc.(AXLA.US)$截至今天上午，該公司股價上漲了近28%。
$Marin Software Inc.(MRIN.US)$隨着Reddit繼續看好該公司，該公司股價上漲了20%以上。
$Ocugen Inc(OCGN.US)$在披露了與巴拉特生物技術公司共同開發的冠狀病毒疫苗的試驗結果後，該公司股價上漲了16%以上。
$Sequential Brands Group Inc.(SQBG.US)$股價上漲了16%以上。在看到週五的成交量很大之後.
$Immutep Ltd(IMMP.US)$在披露IRB批准將於本季度開始的IIb期臨牀試驗後，該公司股價躍升至11%以上。
10 Top Losers
十大輸家
$Ashford Hospitality Trust Inc(AHT.US)$ stock is diving more than 26% after revealing plans for a 1-for-10 reverse stock split.
$POP CULTURE GROUP CO LTD(CPOP.US)$ stock is dropping over 15%, which continues its fall from Friday.
$Nortech Systems Inc(NSYS.US)$ shares are retreating more than 12% after running higher on Friday.
$KANZHUN LIMITED(BZ.US)$ stock is taking an over 9% beating as one of its subsidiaries is being investigated by China's watchdog group.
$Tata Motors Ltd(TTM.US)$ shares are decreasing more than 8% on warnings of chip shortages.
$Alterity Therapeutics Ltd(ATHE.US)$ stock is seeing shares lose 8% of their value in pre-market trading this morning.
$Virpax Pharmaceuticals, Inc.(VRPX.US)$ shares are declining over 7% on no apparent news.
$Staffing 360 Solutions Inc(STAF.US)$ stock is pulling back more than 7% after shares rallied on Friday.
$DouYu International Holdings Limited(DOYU.US)$ shares close out our pre-market stock movers list down over 7% this morning.
$Ashford Hotitality Trust Inc.(AHT.US)$在公佈了10股換1股的反向股票拆分計劃後，該公司股價暴跌逾26%。
$流行文化集團有限公司(CPOP.US)$股價下跌超過15%，這是自上週五以來的持續下跌。
$Nortech Systems Inc.(NSYS.US)$股價在上週五走高後，目前已回落逾12%。
$看準有限公司(BZ.US)$由於其一家子公司正在接受中國監管機構的調查，其股票遭受了超過9%的打擊。
$塔塔汽車有限公司(TTM.US)$由於芯片短缺的警告，該公司股價下跌超過8%。
$Alterity Treeutics Ltd(ATHE.US)$在今天上午的盤前交易中，股票市值下跌了8%。
$Virpax製藥公司(VRPX.US)$在沒有明顯消息的情況下，股價下跌了7%以上。
$人員配備360解決方案公司(STAF.US)$在上週五股價反彈後，股價回落超過7%。
$鬥魚國際控股有限公司(DOYU.US)$今天上午，股票收盤前下跌超過7%。
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在出版之日，威廉·懷特沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點，以InvestorPlace.com為準出版指南.